In this study, we evaluated baseline LTBI screening results in patients treated with TNF antagonists in a 2000-bed tertiary referral hospital in Seoul, South Korea, and determined the incidence and characteristics of active TB according to baseline LTBI status. The gene discussed is TNF; the disease is tuberculosis.